Global Covid-19 Vaccination Market 2023-2027
The covid-19 vaccination market is forecasted to grow by USD -54598.89 million during 2022-2027, accelerating at a CAGR of -29.3% during the forecast period. The report on the covid-19 vaccination market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by expansion of vaccination programs, emergence of new covid-19 variants, and expanded covid-19 vaccine eligibility.
Technavio's covid-19 vaccination market is segmented as below:
By Type
By Distribution Channel
- Government entities
- Hospitals and clinics
- Others
By Geographical Landscape
- North America
- Asia
- Europe
- Rest of World (ROW)
This study identifies the rising r and d investment as one of the prime reasons driving the covid-19 vaccination market growth during the next few years. Also, launch of new covid-19 vaccines and adoption of technology and innovation in covid-19 vaccination market will lead to sizable demand in the market.
The report on the covid-19 vaccination market covers the following areas:
- Covid-19 vaccination market sizing
- Covid-19 vaccination market forecast
- Covid-19 vaccination market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading covid-19 vaccination market vendors that include AIVITA Biomedical Inc., AnGes Inc., AstraZeneca Plc, Bharat Biotech Ltd., CureVac AG, Emergent BioSolutions Inc., Eubiologics Co. Ltd., Genexine Inc., GreenLight Biosciences Holdings PBC, Inovio Pharmaceuticals Inc., Johnson and Johnson, Moderna Inc., Novavax Inc., Pfizer Inc., Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., Tadbir innovation pharmaceutical Co., The Gamaleya National Center, and Zydus Lifesciences Ltd.. Also, the covid-19 vaccination market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.